Add BrightSurf on Google Email

The Lancet: New report details “massive global failures” of COVID-19 response, calls for improved multilateral cooperation to end pandemic and effectively manage future global health threats

The Lancet Commission report highlights widespread, global failures in the COVID-19 response, resulting in millions of preventable deaths and reversed progress towards UN SDGs. The report calls for strengthened multilateral cooperation, improved technology, and international health financing to address future health threats.

SourceThe Lancet·JournalThe Lancet·TypeSystematic review·DateSep 14, 2022

Study: Minority, immigrant populations faced misinformation, hostility when seeking COVID-19 information online

A new study from the University of Kansas found that racial and ethnic minority populations in the US faced unique challenges while seeking COVID-19 information online, including misinformation, harassment, and hostility. Younger and healthier individuals were more resistant to vaccination due to lower perceived risk and benefit.

SourceUniversity of Kansas·JournalConvergence The International Journal of Research into New Media Technologies·TypeSurvey·DateSep 8, 2022

Rutgers study indicates who faces highest risk of HPV infection and anal cancer

A Rutgers study found that previous sexually transmitted infections and multiple sexual partners increase the risk of new HPV infections in men who have sex with men, other cisgender sexual minority men, and transgender women. The study also highlights the importance of HPV vaccination and regular screening to prevent anal cancer.

SourceRutgers University·JournalAmerican Journal of Men s Health·TypeSurvey·DateSep 7, 2022

Those suffering from autoimmune diseases require a third coronavirus vaccination

A study published in The Lancet Rheumatology found that booster vaccinations significantly increase immune protection for individuals with autoimmune diseases such as rheumatism and inflammatory bowel disease. Most patients experienced no significant side effects after receiving a third vaccination, and their antibodies effectively pro...

SourceFriedrich-Alexander-Universität Erlangen-Nürnberg·JournalThe Lancet Rheumatology·DateSep 2, 2022

New research shows no link between COVID-19 vaccination during pregnancy and higher risk of preterm birth or stillbirth

A population-based retrospective cohort study found that COVID-19 vaccination during pregnancy is not associated with an increased risk of preterm birth, small for gestational age at birth, or stillbirth. The study concluded that COVID-19 vaccination during pregnancy can inform evidence-based decision-making about its safety.

SourceUniversity of Ottawa·JournalThe BMJ·TypeData/statistical analysis·DateAug 29, 2022

Efficacy, cash and more will increase booster shot acceptance

The study found that a booster shot's effectiveness is the primary factor influencing people's willingness to receive it. Those who believe in vaccine efficacy are more likely to accept the booster shot, especially if it is made by Moderna or Pfizer. A partisan divide persists, with Democrats more willing and Republicans less willing.

SourceCornell University·JournalSocial Science & Medicine·DateAug 29, 2022

Study: Slogans protesting federal COVID-19 vaccine mandate displayed three themes

A recent study found three distinct themes in slogans protesting federal COVID-19 vaccine mandates: Support for individual freedom/rights, opposition to government control, and anti-science misinformation/disinformation. The majority of slogans opposing vaccines were about individual rights or resistance to government control.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalFrontiers in Communication·TypeContent analysis·DateAug 26, 2022

UC Davis Health study reports on the safety, efficacy of tecovirimat in treating monkeypox

A UC Davis Health study found that tecovirimat appears to be safe and effective for treating monkeypox symptoms and skin lesions. The study, which included 25 patients with confirmed monkeypox infection, showed that 92% of patients had lesions in their genital or anal area, while 40% healed from their lesions within a week of treatment.

SourceUniversity of California - Davis Health·JournalJAMA·TypeCase study·DateAug 26, 2022

University of Cincinnati research examines COVID-19 vaccine hesitancy

The study examines the complex factors contributing to vaccine hesitancy, including mixed media messages and concerns about effectiveness and safety. The researchers found that highly educated individuals were among those hesitant to receive the vaccine, highlighting the need for targeted education approaches.

SourceUniversity of Cincinnati·JournalInternational Journal of Environmental Research and Public Health·TypeSurvey·DateAug 25, 2022

Change in surgical volume during COVID-19

A severe decline in surgical procedure volumes was observed across various subspecialties during the COVID-19 peak. The overall volume failed to fully recover after the peak and vaccine release periods, with varying rates of recovery among different specialties.

SourceJAMA Network·JournalJAMA Network Open·DateAug 18, 2022

Steepest annual rise in advanced cervical cancer in US among White women

Advanced cervical cancer rates have been rising in the US, with a significant increase among White women and higher prevalence among Black women, particularly those in their mid-to-late 50s. The study found that obesity and older age at first birth may contribute to the rise in this type of cervical cancer.

SourceBMJ Group·JournalInternational Journal of Gynecological Cancer·TypeObservational study·DateAug 18, 2022

Quality Improvement Program increases pneumococcal vaccination in adults with advanced kidney disease

A quality improvement program increased pneumococcal vaccination rates from 53% to 70% in adults aged 18-64 years with stage 4 and 5 chronic kidney disease. The intervention, which utilized electronic best practice alerts within the electronic medical record, improved vaccination rates primarily among this high-risk group.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateAug 17, 2022

Monkeypox virus found in anal samples from asymptomatic MSM

Researchers discovered 13 cases of asymptomatic MSM with positive monkeypox virus PCR results in anal samples, raising concerns about the outbreak's transmission dynamics. The findings suggest that vaccination may not be an effective strategy for preventing infection, highlighting the need for expanded public health interventions.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeObservational study·DateAug 15, 2022

New MIT research forecasts effect of two-dose vaccine allocation strategies on cumulative number of infections and death in US

A new MIT model simulates vaccine allocation strategies to predict the effect on cumulative deaths and infections in the US. The research finds that allocating more than 50% of available doses to non-vaccinated individuals can significantly increase lives saved and reduce infections.

SourceMIT Sloan School of Management·JournalPLOS Global Public Health·TypeExperimental study·DateAug 15, 2022

Extending the shelf life of vaccines

A new hydrogel-based platform increases vaccine thermal stability, enabling distribution in diverse regions without strict temperature control. The technology has the potential to reduce economic costs and health risks associated with cold chain logistics.

SourceETH Zurich·JournalScience Advances·TypeExperimental study·DateAug 5, 2022

Immune boosting benefits of tuberculosis vaccine seen in infants more than a year after vaccination

A new study has shown that the TB vaccine can produce a long-lasting 'trained immunity response' in infants, lasting more than 14 months after vaccination. The research found that the BCG vaccine's off-target effects on the immune system can lead to reprogramming of genes in a specific blood cell type, known as monocytes.

SourceMurdoch Childrens Research Institute·JournalScience Advances·TypeRandomized controlled/clinical trial·DateAug 5, 2022

Effectiveness associated with Pfizer/BioNTech vaccine against emergency department, urgent care encounters for SARS-CoV-2 infection among adolescents

The Pfizer/BioNTech COVID-19 vaccine demonstrated high levels of protection against emergency department and urgent care encounters related to Delta and Omicron variants. A third dose improved protection against Omicron beyond initial two-dose efficacy, emphasizing the importance of boosters for adolescents aged 12-17.

SourceJAMA Network·JournalJAMA Network Open·DateAug 3, 2022